Lobbying gives US industry “improved guidance” on research-only diagnostic
This article was originally published in Clinica
Executive Summary
The US in vitro diagnostics industry has broadly welcomed the FDA’s final guidance on “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only”, which was issued on 25 November.